1-8 of 8
Mark P. Chao
Close
Sort by
Journal Articles

Macrophage Activation By Dual PI3K-δ/γ Inhibition Enhances Anti-CD47-Mediated Phagocytosis and Prolongs Survival in DLBCL

James Godfrey, MD, Wenjun Kang, MS, Lei Huang, PhD, Silvia Coma, PhD, Roy Maute, PhD, Mark P. Chao, MD PhD, Jonathan A Pachter, PhD, Sonali Smith, MD, Justin Kline, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40.
https://doi.org/10.1182/blood-2020-143304
Published: 2020
Journal Articles

Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists

Konstantin Yakimchuk, Mohammad Sharif Hasni, Jiyu Guan, Mark P. Chao, Birgitta Sander, Sam Okret
Journal: Blood
Blood (2014) 123 (13): 2054–2061.
https://doi.org/10.1182/blood-2013-07-517292
Published: 2014
Includes: Supplemental data
Journal Articles

Two faces of ET: CALR and JAK2

Mark P. Chao, Jason Gotlib
Journal: Blood
Blood (2014) 123 (10): 1438–1440.
https://doi.org/10.1182/blood-2014-01-547596
Published: 2014
Journal Articles

Response: mechanisms of targeting CD47-SIRPα in hematologic malignancies

Mark P. Chao, Ravindra Majeti, Irving Weissman
Journal: Blood
Blood (2012) 119 (18): 4334–4335.
https://doi.org/10.1182/blood-2012-02-411249
Published: 2012
Journal Articles

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy

Mark P. Chao, Chad Tang, Russell K. Pachynski, Robert Chin, Ravindra Majeti, Irving L. Weissman
Journal: Blood
Blood (2011) 118 (18): 4890–4901.
https://doi.org/10.1182/blood-2011-02-338020
Published: 2011
Includes: Supplemental data
Journal Articles

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Kipp Weiskopf, Ash A. Alizadeh, Josh Brody, Antonia Müller, Russell Pachynski, Debra Czerwinski, Steven Coutre, Mark P. Chao, Lieping Chen, Thomas F. Tedder, Ronald Levy
Journal: Blood
Blood (2011) 117 (8): 2423–2432.
https://doi.org/10.1182/blood-2010-08-301945
Published: 2011
Includes: Supplemental data
Journal Articles

Therapeutic Antibody Targeting of CD47 Synergizes with Rituximab to Completely Eradicate Human B-Cell Lymphoma Xenografts.

Mark P. Chao, BA, Ash A Alizadeh, MD, PhD, Chad Z. Tang, MS, June Helen Myklebust, PhD, Bindu Varghese, PhD, Max Jan, BA, Ronald Levy, MD, Irving L. Weissman, MD, Ravindra Majeti, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2716.
https://doi.org/10.1182/blood.V114.22.2716.2716
Published: 2009
Journal Articles

CD47 Is An Independent Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Ravindra Majeti, MD, PhD, Mark P. Chao, Ash A. Alizadeh, MD, PhD, Wendy W. Pang, Irving L. Weissman, MD
Journal: Blood
Blood (2008) 112 (11): 766.
https://doi.org/10.1182/blood.V112.11.766.766
Published: 2008